Promoting informed decision making about prostate cancer screening.
作者信息
Chan E C
机构信息
Division of General Internal Medicine, Department of Medicine, University of Texas-Houston Health Science Center, 6431 Fannin, 1.122 MSB, Houston, TX 77030, USA.
出版信息
Compr Ther. 2001 Fall;27(3):195-201. doi: 10.1007/s12019-001-0014-4.
PMID:11569319
Abstract
Because prostate cancer screening with prostate specific antigen is controversial, informed consent is recommended. Physicians are encouraged to discuss facts about prostate specific antigen with patients and to supplement such discussions with informational brochures or videotapes.
摘要
相似文献
1
Promoting informed decision making about prostate cancer screening.
Compr Ther. 2001 Fall;27(3):195-201. doi: 10.1007/s12019-001-0014-4.
2
Cultural sensitivity and informed decision making about prostate cancer screening.
J Community Health. 2003 Dec;28(6):393-405. doi: 10.1023/a:1026072022853.
3
The impact of informed consent on patient interest in prostate-specific antigen screening.
Arch Intern Med. 1996 Jun 24;156(12):1333-6.
4
Informed consent for prostate cancer screening--a call for equity in medical interventions.
Urology. 2003 Jan;61(1):15-6. doi: 10.1016/s0090-4295(02)02008-3.
5
Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.
BJU Int. 2005 Apr;95 Suppl 3:16-32. doi: 10.1111/j.1464-410x.2005.05440.x.
6
Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial.
Ann Fam Med. 2013 Jul-Aug;11(4):324-34. doi: 10.1370/afm.1550.
7
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
J Fam Pract. 1999 Sep;48(9):682-8.
8
To screen or not to screen? Prostate cancer screening: why it's not for every man.
Medscape J Med. 2008;10(8):181. Epub 2008 Aug 3.
9
Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits.
Ann Fam Med. 2013 Jul-Aug;11(4):315-23. doi: 10.1370/afm.1509.
10
Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness.
Med Clin North Am. 1999 Nov;83(6):1423-42, vi. doi: 10.1016/s0025-7125(05)70173-5.
引用本文的文献
1
Developing a conceptual map of patient information needs in prostate cancer screening.
NI 2012 (2012). 2012 Jun 23;2012:273. eCollection 2012.
2
Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.
J Am Geriatr Soc. 2010 Apr;58(4):674-80. doi: 10.1111/j.1532-5415.2010.02761.x. Epub 2010 Mar 22.
3
Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial.
Am J Prev Med. 2007 Aug;33(2):83-90. doi: 10.1016/j.amepre.2007.03.018.
Zotero 插件